Scientific experts support addition of “life-saving” prostate cancer early detection programmes

On 2 March 2022 the Chief Scientific Advisors to the European Commission published a scientific opinion which is in favour of the development of EU wide guidelines on risk stratified prostate specific antigen (PSA)-based prostate cancer screening, in combination with additional MRI scanning as a follow-up test. The Chief Advisors following the evidence report from […]

EAU Statement on the War in Ukraine

The EAU, as a scientific European professional medical association with members from across the world, is absolutely against the use of violence in Ukraine. We oppose wars as a means of settling disputes of any kind and hope for a swift and peaceful resolution. We support our Ukrainian members and all of our members who […]

Systematic Review With Meta-Analysis: Diagnostic, Prognostic and Clinicopathological Significance of CircRNA Expression in Renal Cancer.

Renal cancer (RC) is one of the most common malignant tumors of the urinary system, and molecular targets for the specific diagnosis and treatment of RC have been widely explored. The purpose of this study was to systematically analyze circular RNAs (circRNAs), which may serve as novel tumor markers in terms of the diagnosis, prognosis […]

Optimal Dissemination of Scientific Manuscripts via Social Media: A Prospective Trial Comparing Visual Abstracts Versus Key Figures in Consecutive Original Manuscripts Published in European Urology.

Visual abstracts (VAs) are graphical representations of the key findings in manuscripts and have been adopted by many journals to improve content dissemination via social media. We sought to assess whether VAs, compared to key figures (KFs), increased reader engagement via social media using articles published in European Urology.

May outcomes of RALP performed after an initial surveillance strategy differ from those from immediate surgery? A propensity score matched analysis on 362 patients undergoing surgery at a referral center.

Introduction Active surveillance (AS) is a treatment strategy for low-risk PCa patients, with extended indication to some intermediate-risk PCa. However, active treatment is necessary in case of disease progression and robotic radical prostatectomy (RALP) is one of the treatment modalities.

Pain and health-related quality of life with olaparib versus physician’s choice of next-generation hormonal drug in patients with metastatic castration-resistant prostate cancer with homologous recombination repair gene alterations (PROfound): an open-lab

The PROfound study showed significantly improved radiographical progression-free survival and overall survival in men with metastatic castration-resistant prostate cancer with alterations in homologous recombination repair genes and disease progression on a previous next-generation hormonal drug who received olaparib then those who received control.